Warning Letters Special Report: Why Investigations Once Again Led Drug GMP Problem Areas In 2022 And What To Do About It

 
• By Bowman Cox
  
2022 Warning Letters Special Report
many poor investigations and a few better practices • Source: Shutterstock

More from Manufacturing

More from Compliance